We are live on ! Find out more
AI

Alphabet Inc Portfolio holdings

AUM $4.02B
1-Year Est. Return 215.74%
This Fund
S&P 500
This Quarter Est. Return
-21.5%
1 Year Est. Return
+215.74%
3 Year Est. Return
+350.01%
5 Year Est. Return
+242.03%
10 Year Est. Return
+998.87%
AUM
$3.08B
AUM Growth
-$1.06B
Cap. Flow
+$103M
Cap. Flow %
3.35%
Top 10 Hldgs %
78.16%
Holding
61
New
3
Increased
3
Reduced
6
Closed
1

Top Buys

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$152M
2
SNOW icon
Snowflake
SNOW
+$138M
3
RANI icon
Rani Therapeutics
RANI
+$11.9M
4
BHIL
Benson Hill, Inc.
BHIL
+$2.37M
5
HLTH
Cue Health Inc. Common Stock
HLTH
+$244K

Top Sells

Rank Stock Value
1
TOST icon
Toast
TOST
+$182M
2
VERA icon
Vera Therapeutics
VERA
+$8.87M
3
S icon
SentinelOne
S
+$4.8M
4
UBER icon
Uber
UBER
+$2.07M
5
RAPT
RAPT Therapeutics
RAPT
+$2.07M

Sector Composition

Rank Sector Weight
1 Healthcare 53.88%
2 Technology 34.52%
3 Industrials 7.5%
4 Financials 2.21%
5 Consumer Staples 1.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DUOL icon
26
Duolingo
DUOL
$6.53B
$13.7M 0.45%
144,444
– –
RAPT
27
DELISTED
RAPT Therapeutics
RAPT
$11.9M 0.39%
67,534
-10,936
-14% -$2.07M
TNYA icon
28
Tenaya Therapeutics
TNYA
$160M
$10.8M 0.35%
915,705
– –
KRON
29
DELISTED
Kronos Bio
KRON
$10.4M 0.34%
1,438,232
– –
DNTH icon
30
Dianthus Therapeutics
DNTH
$5.69B
$9.68M 0.31%
208,696
– –
RANI icon
31
Rani Therapeutics
RANI
$94.8M
$9.64M 0.31%
+714,471
New +$11.9M
IDYA icon
32
IDEAYA Biosciences
IDYA
$3.43B
$8.43M 0.27%
753,187
– –
BRNS
33
Barinthus Biotherapeutics
BRNS
$23.4M
$7.87M 0.26%
1,513,644
-190,700
-11% -$1.54M
SPRO icon
34
Spero Therapeutics
SPRO
$68.9M
$7.74M 0.25%
889,979
– –
FHTX icon
35
Foghorn Therapeutics
FHTX
$278M
$7.63M 0.25%
500,901
– –
VERA icon
36
Vera Therapeutics
VERA
$2.33B
$7.08M 0.23%
301,580
-412,078
-58% -$8.87M
NEWR
37
DELISTED
New Relic, Inc.
NEWR
$6.09M 0.2%
91,132
– –
FULC icon
38
Fulcrum Therapeutics
FULC
$241M
$6.04M 0.2%
255,452
– –
DBTX
39
DELISTED
Decibel Therapeutics, Inc. Common Stock
DBTX
$4.97M 0.16%
1,636,258
– –
TSHA icon
40
Taysha Gene Therapies
TSHA
$1.61B
$4.18M 0.14%
640,882
– –
OMIC
41
DELISTED
Singular Genomics Systems, Inc. Common Stock
OMIC
$3.7M 0.12%
19,553
– –
EVLO
42
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$3.6M 0.12%
53,025
– –
AMPL icon
43
Amplitude
AMPL
$1.18B
$3.49M 0.11%
189,447
– –
HYPR icon
44
Hyperfine
HYPR
$88.4M
$3.18M 0.1%
898,720
– –
TCRX icon
45
TScan Therapeutics
TCRX
$48.5M
$3.02M 0.1%
1,077,080
– –
AUTL
46
Autolus Therapeutics
AUTL
$389M
$2.91M 0.09%
698,262
– –
ALEC icon
47
Alector
ALEC
$169M
$2.51M 0.08%
175,866
– –
NVTA
48
DELISTED
Invitae Corporation
NVTA
$1.72M 0.06%
215,965
– –
EXAS
49
DELISTED
Exact Sciences
EXAS
$1.62M 0.05%
23,205
– –
OPRT icon
50
Oportun Financial
OPRT
$262M
$1.36M 0.04%
94,788
– –
1
2
3

Similar funds

JSW
Journey Strategic Wealth Summit, New Jersey $4.03B AUM 33.12% 1-Year Est. Return
BWA
Brave Warrior Advisors New York $4.04B AUM 1.15% 1-Year Est. Return
MAM
Martingale Asset Management Boston, Massachusetts $3.99B AUM 22.65% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
USCWA
U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return
ICP
Ilex Capital Partners London, United Kingdom $4.06B AUM 6.11% 1-Year Est. Return
CA
CSM Advisors Warrendale, Pennsylvania $4.07B AUM 29.62% 1-Year Est. Return
MGP
Metis Global Partners San Diego, California $4.07B AUM 30.82% 1-Year Est. Return

Alphabet Inc's Q1 2022 Portfolio in Review

As of Q1 2022, Alphabet Inc held 61 positions worth $3.08B, down 26% from $4.14B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Alphabet Inc deployed $103M of net new capital in Q1 2022, opening 3 new positions and adding to 3 existing holdings. Its largest new stake was Snowflake: 535,604 shares worth $123M.

By sector, the portfolio is most concentrated in Healthcare at 54% of assets, up from 47% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Toast, an estimated $182M trimmed.

  • Alphabet Inc's largest Q1 2022 buy was Snowflake: 535,604 shares worth $123M.
  • Alphabet Inc added most to DexCom in Q1 2022, an estimated $152M increase.
  • Alphabet Inc's biggest Q1 2022 reduction was Toast, cutting an estimated $182M.
  • Alphabet Inc fully exited Uber in Q1 2022, selling an estimated $2.07M.
  • Alphabet Inc's ten largest holdings make up 78% of its $3.08B portfolio in Q1 2022.
  • Alphabet Inc opened 3 new positions and closed 1 in Q1 2022.
  • Alphabet Inc's portfolio value fell 26% quarter-over-quarter to $3.08B.

Based on Alphabet Inc's 13F filing for Q1 2022, filed 15 Nov 2022.